- Home
- CABA vs AZ Comparison
CABA vs AZ Comparison
Compare CABA & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CABA | AZ |
|---|---|---|
| Founded | 2017 | 2018 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.7M | 228.5M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CABA | AZ |
|---|---|---|
| Price | $3.63 | $5.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $14.57 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 3.0M | 475.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.87 |
| Revenue Next Year | N/A | $480.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $5.00 |
| 52 Week High | $3.78 | $12.36 |
Technical Indicators
Market Signals| Indicator | CABA | AZ |
|---|---|---|
| Relative Strength Index (RSI) | 71.51 | 38.00 |
| Support Level | $2.11 | $5.10 |
| Resistance Level | N/A | $6.63 |
| Average True Range (ATR) | 0.26 | 0.41 |
| MACD | 0.07 | -0.07 |
| Stochastic Oscillator | 98.94 | 34.43 |
Price Performance
Historical ComparisonAbout CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.